Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Indivior PLC - Ordinary Shares (NQ:INDV)

9.010 +0.070 (+0.78%)
Streaming Delayed Price Updated: 9:39 AM EDT, Apr 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Indivior PLC - Ordinary Shares

< Previous 1 2 3 4 Next >
Q3 2023 Earnings Season: Record Revenue, Robust Performance, Consistent Results From Three Cannabis Companies
Nova Cannabis Inc. Reports Record Q3 2023 Revenue, Achieving Gross Margin Growth Nova Cannabis Inc. (TSX: NOVC) (OTCQB: NVACF) released its unaudited condensed interim consolidated financial statements... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
What's Going On With Pharma Company Indivior's Shares Today?
Indivior PLC (NASDAQ: INDV) shares are trading higher by around 6% after the company inked a deal to  
Via Benzinga
Publicly-Traded Addiction Treatment Co. Signs Exclusive Licensing Agreement With Alar Pharmaceuticals
Addiction treatment company Indivior PLC (NASDAQ: INDV) obtained exclusive global rights to develop, produce and commercialize Alar Pharmaceuticals’ portfolio of long-acting injectable formulations... 
Via Benzinga
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations. 
Via Benzinga
Indivior Reaches Agreement With End Payor Class To Resolve Their Antitrust Multi-District Litigation Claims
Indivior Inc., a subsidiary of Indivior PLC (NASDAQ: INDV) has reached an agreement to resolve the claims brought by the end payor class of litigants in the In re Suboxone Antitrust Litigation... 
Via Benzinga
Drug Maker Novartis Stock Shows Rising Relative Strength
Novartis stock had its Relative Strength Rating upgraded to 73 Monday -- a nice improvement, but still shy of the preferred 80-plus score. 
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 32 companies reached new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.